Example: Heart Attack

Clinical Trials on Myoclonus Epilepsy

Total 22 results

NCT03400371

Recruiting

Biology of Juvenile Myoclonic Epilepsy

Conditions: Juvenile Myoclonic Epilepsy
NCT01450423

Unknown status

Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy

Conditions: Epilepsy; Epilepsia; Epileptic Seizures; Seizure Disorder
NCT00639119

Unknown status

Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type

Conditions: Unverricht-Lundborg Syndrome
NCT00693017

Terminated

Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy

Conditions: Epilepsy
NCT03857451

Active, not recruiting

Treatment of Gait Disorders in Children With Dravet Syndrome

Conditions: Dravet Syndrome; Severe Myoclonic Epilepsy of Infancy
NCT00006191

Completed

Effect of Levetiracetam on Brain Excitability

Conditions: Healthy; Myoclonic Epilepsy
NCT00150774

Completed

Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults

Conditions: Generalized Convulsive Epilepsy
NCT03351569

Unknown status

Intravenous Immunoglobulin for Unverricht-Lundborg Disease.

Conditions: Unverricht-Lundborg Disease
NCT03876522

Active, not recruiting

Natural History and Functional Status Study of Patients With Lafora Disease

Conditions: Lafora Disease
NCT04740476

Enrolling by invitation

An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome

Conditions: Dravet Syndrome
NCT04442295

Recruiting

An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome

Conditions: Dravet Syndrome
NCT00368251

Completed

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults

Conditions: Unverricht-Lundborg Disease
NCT00357669

Completed

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

Conditions: Unverricht-Lundborg Disease
NCT01118962

Completed

Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Conditions: Epilepsy
NCT01118949

Completed

Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Conditions: Epilepsy
NCT04537832

Recruiting

Natural History Study of Infants and Children With SCN1A-positive Dravet Syndrome

Conditions: Dravet Syndrome
NCT00007124

Completed

Ketogenic Diet in Lafora Disease

Conditions: Lafora Disease
NCT02023866

Completed

Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease

Conditions: Inherited Mitochondrial Disease, Including Leigh Syndrome
NCT04235452

Completed

Electrophysiological Characteristics and Anatomical Differentiation of Epileptic and Non-epileptic Myoclonus.

Conditions: Myoclonus; Evoked Potential
NCT00006176

Completed

Clinical and Genetic Studies of Familial Presenile Dementia With Neuronal Inclusion Bodies

Conditions: Familial Dementia With Neuroserpin Inclusion Bodies; Nervous System Heredodegenerative Disorder
NCT02473445

Terminated

A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease

Conditions: Mitochondrial Diseases
NCT01694940

Recruiting

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

Conditions: Mitochondrial Disorders; Mitochondrial Genetic Disorders; Mitochondrial Diseases; Disorder of Mitochondrial Respiratory Chain Complexes; Deletion and Duplication of Mitochondrial DNA